# Piramal Healthcare (Canada) Ltd. – FDA Inspection, May 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/piramal-healthcare-canada-ltd/f50189f2-3cfd-41b5-bd77-0758aeea31a2
Source feed: FDA_Inspections

> FDA inspection 1055172 of Piramal Healthcare (Canada) Ltd., May 18, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055172
- Company Name: Piramal Healthcare (Canada) Ltd.
- Inspection Date: 2018-05-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1275272 - 2025-05-30](https://www.keypedia.com/records/fda_inspections/piramal-healthcare-canada-ltd/dc0769c2-5d0a-4347-a3bd-dca9f5eab765)
- FDA Inspection 887844 - 2014-06-27
- FDA Inspection 737264 - 2011-07-15
- FDA Inspection 546753 - 2008-10-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)

Company: https://www.keypedia.com/companies/piramal-healthcare-canada-ltd/6e8dc864-2009-43ed-a480-ca343a75872d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c